[EN] INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF<br/>[FR] INHIBITEURS DE LA KALLIKRÉINE PLASMATIQUE ET UTILISATIONS ASSOCIÉES
申请人:DYAX CORP
公开号:WO2019028362A1
公开(公告)日:2019-02-07
Provided herein are compounds that inhibit pKal, a serine protease whose activity is responsible for proteolytically cleaving kininogen and generating the potent vasodilator and pro-inflammatory peptide bradykinin, which can lead to painful and debilitating inflammatory attacks (e.g., edema). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating pKal-related diseases and disorders (e.g., edema) with the compounds in a subject, by administering the compounds and/or compositions described herein.
First, serendipitous and intriguing hydrolysis of a tertiary nitroalkane
作者:Michel P. Crozet、Sophie Lapouge、Mustapha Kaafarani、Patrice Vanelle
DOI:10.1016/s0040-4039(00)76826-2
日期:1994.5
The hydrolysis of 1,2-dimethyl-4-(1,1,2-trimethyl-2-nitropropyl)imidazole which leads to two tertiary alcohols formed respectively by CNO2 and CC bondfission, is the first example of hydrolysis of a tertiary nitroalkane. It might be explained by an intramolecular nucleophilic catalysis favored by a double gem-dimethyl effect and a possible anchimeric assistance by imidazole group.